Cerus
CERS
$1.71
Share price
0.59%
Change (1 day)
-25.97%
Change (1 year)
Categories
Cerus (CERS) - Total debt
Total debt on the balance sheet as of December 2023 : $95.99 M
According to Cerus's latest financial reports the company's total debt is $95.99 M. A company’s total debt is the sum of all current and non-current debts.
Cerus - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $95.99 M | 10.04% |
| 2022-12-31 | $87.23 M | -0.4% |
| 2021-12-31 | $87.58 M | 30.94% |
| 2020-12-31 | $66.89 M | 3.79% |
| 2019-12-31 | $64.45 M | 115.77% |
| 2018-12-31 | $29.87 M | 0.24% |
| 2017-12-31 | $29.79 M | 53.8% |
| 2016-12-31 | $19.37 M | -2.17% |
| 2015-12-31 | $19.8 M | 100.61% |
| 2014-12-31 | $9.87 M | 193.29% |
| 2013-12-31 | $3.36 M | -56.42% |
| 2012-12-31 | $7.72 M | 7.04% |
| 2011-12-31 | $7.21 M | 47.45% |
| 2010-12-31 | $4.89 M | 20291.67% |
| 2009-12-31 | $0.02 M | |
| 2008-12-31 | $N/A | -100% |
| 2007-12-31 | $0.03 M | -72.41% |
| 2006-12-31 | $0.11 M | -97.66% |
| 2005-12-31 | $4.96 M | -87.28% |
| 2004-12-31 | $39 M | -30.17% |
| 2003-12-31 | $55.85 M | 109415.69% |
| 2002-12-31 | $0.05 M | -37.8% |
| 2001-12-31 | $0.08 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $9.49 B | 9,787.60% | 🇺🇸 USA |
 Utah Medical Products UTMD | $0.29 M | -99.69% | 🇺🇸 USA |
 Haemonetics HAE | $0.87 B | 806.87% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $41.84 M | -56.41% | 🇺🇸 USA |